-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Finance App News, Ling Rui Pharmaceutical (600285.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” for the flurbiprofen gel patch approved and issued by the State Drug Administration. Flubiprofen gel patch is a topical non-steroidal anti-inflammatory drug with analgesic and anti-inflammatory effects. It is suitable for osteoarthritis, periodontitis, tendon and tenosynovitis, inflammation around the tendon sheath, lateral epicondylitis of the humerus (tennis elbow), muscle pain, and swelling and pain caused by trauma. This product is a Class B type of national medical insurance.
Share
Listen to the news
Zhitong Finance App News, Ling Rui Pharmaceutical (600285.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” for the flurbiprofen gel patch approved and issued by the State Drug Administration. Flubiprofen gel patch is a topical non-steroidal anti-inflammatory drug with analgesic and anti-inflammatory effects. It is suitable for osteoarthritis, periodontitis, tendon and tenosynovitis, inflammation around the tendon sheath, lateral epicondylitis of the humerus (tennis elbow), muscle pain, and swelling and pain caused by trauma. This product is a Class B type of national medical insurance.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending